Tag: Janssen Biotech

Merck Launches Renflexis, a Biosimilar Version of Remicade

Merck has launched a biosimilar version of Remicade, Johnson & Johnson’s blockbuster drug, writes John George for Philadelphia Business Journal.

Biosimilar products are designed…

janssen

Janssen Biotech Enters Licensing Agreement with California’s Protagonist Therapeutics

Horsham’s Janssen Biotech has entered into a global licensing and collaboration agreement with California’s Protagonist Therapeutics, writes John George for Philadelphia Business Journal…

Scandal Star Helps Janssen Biotech Raise Psoriasis Awareness

Horsham’s Janssen Biotech has partnered with the National Psoriasis Foundation to launch ‘Psoriasis: The Inside Story,’ a campaign that puts the spotlight on the…